CAR T Promises Longer Relief For Myasthenia Gravis

RNA CAR T therapy Descartes‑08 targets BCMA‑positive plasma cells and delivers year‑long symptom relief in myasthenia gravis ...
Fierce Biotech

FDA signals tailored approach to ‘carefully shepherd’ CAR-T therapy for autoimmune diseases

While interested in CAR-T therapies’ potential to achieve durable, drug-free remission in serious autoimmune conditions, the ...
Healio

Rheumatologists view CAR T-cell therapy as ‘revolutionary,’ but cost, safety temper enthusiasm

Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain hesitant on whether its efficacy outweighs the possible risks, according to ...
Morningstar

Qihan Biotech Presents New Clinical Data on Allogeneic CAR-T Cell Therapies and Preclinical Data on In Vivo CAR-T at the American Society of Hematology (ASH) Annual Meeting

Qihan Biotech Presents New Clinical Data on Allogeneic CAR-T Cell Therapies and Preclinical Data on In Vivo CAR-T at the American Society of Hematology (ASH) Annual Meeting – Clinical data from ...
The American Journal of Managed Care

Sequencing CAR T and Bispecifics for Multiple Myeloma: Tyler Sandahl, PharmD

FDA approval criteria primarily dictate the sequencing of multiple myeloma therapies, often restricting bispecific antibodies to later treatment lines. Institutional practices vary in using CAR T-cell ...
Healio

Study: Autoimmune impacts of CAR T-cell therapy require monitoring

Please provide your email address to receive an email when new articles are posted on . CAR T-cell therapy for cancer may be associated with new-onset autoimmune disease. Autoimmune events in after ...
Medical Xpress

CAR-T therapy yields long-term survival for patients with lymphoma

A study published in the Journal of Clinical Oncology confirms that one of the first Food and Drug Administration-approved CAR-T cell therapies offers long-term survival and potential cures for adult ...